drug pricing

Big Pharma Employs UK Drug Pricing Tactics Across Europe

Pharmaceutical companies are replicating UK-style market access strategies to influence drug pricing negotiations in other European countries, impacting national healthcare budgets.

Pharmacy Benefit Manager Reforms Address Systemic Issues

New legislative and regulatory reforms aim to rectify the 'fundamentally broken' pharmacy benefit manager (PBM) system, targeting opaque pricing and rebate practices.